IRIS Accounts Production v24.2.0.383 11659362 Board of Directors 1.12.22 30.11.23 30.11.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh116593622022-11-30116593622023-11-30116593622022-12-012023-11-30116593622021-11-30116593622021-12-012022-11-30116593622022-11-3011659362ns15:EnglandWales2022-12-012023-11-3011659362ns14:PoundSterling2022-12-012023-11-3011659362ns10:Director12022-12-012023-11-3011659362ns10:PrivateLimitedCompanyLtd2022-12-012023-11-3011659362ns10:SmallEntities2022-12-012023-11-3011659362ns10:AuditExempt-NoAccountantsReport2022-12-012023-11-3011659362ns10:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3011659362ns10:SmallCompaniesRegimeForAccounts2022-12-012023-11-3011659362ns10:FullAccounts2022-12-012023-11-3011659362ns10:Director22022-12-012023-11-3011659362ns10:RegisteredOffice2022-12-012023-11-3011659362ns5:CurrentFinancialInstruments2023-11-3011659362ns5:CurrentFinancialInstruments2022-11-3011659362ns5:ShareCapital2023-11-3011659362ns5:ShareCapital2022-11-3011659362ns5:RetainedEarningsAccumulatedLosses2023-11-3011659362ns5:RetainedEarningsAccumulatedLosses2022-11-3011659362ns5:PlantMachinery2022-12-012023-11-3011659362ns5:MotorVehicles2022-12-012023-11-3011659362ns5:ComputerEquipment2022-12-012023-11-3011659362ns5:PlantMachinery2022-11-3011659362ns5:MotorVehicles2022-11-3011659362ns5:ComputerEquipment2022-11-3011659362ns5:PlantMachinery2023-11-3011659362ns5:MotorVehicles2023-11-3011659362ns5:ComputerEquipment2023-11-3011659362ns5:PlantMachinery2022-11-3011659362ns5:MotorVehicles2022-11-3011659362ns5:ComputerEquipment2022-11-3011659362ns5:CostValuation2022-11-3011659362ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-11-3011659362ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-11-30
REGISTERED NUMBER: 11659362 (England and Wales)









CAMBRIDGE MEDICAL PARTNERS LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 NOVEMBER 2023






CAMBRIDGE MEDICAL PARTNERS LIMITED (REGISTERED NUMBER: 11659362)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CAMBRIDGE MEDICAL PARTNERS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 NOVEMBER 2023







DIRECTORS: Dr D C Stokes
Dr N L Wilson





REGISTERED OFFICE: Station House
North Street
Havant
Hampshire
PO9 1QU





REGISTERED NUMBER: 11659362 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

CAMBRIDGE MEDICAL PARTNERS LIMITED (REGISTERED NUMBER: 11659362)

BALANCE SHEET
30 NOVEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 17,737 1,017
Investments 5 3,150 3,150
20,887 4,167

CURRENT ASSETS
Debtors 6 3,659 -
Cash at bank 120,069 140,962
123,728 140,962
CREDITORS
Amounts falling due within one year 7 53,245 63,793
NET CURRENT ASSETS 70,483 77,169
TOTAL ASSETS LESS CURRENT
LIABILITIES

91,370

81,336

PROVISIONS FOR LIABILITIES 254 193
NET ASSETS 91,116 81,143

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 91,016 81,043
SHAREHOLDERS' FUNDS 91,116 81,143

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CAMBRIDGE MEDICAL PARTNERS LIMITED (REGISTERED NUMBER: 11659362)

BALANCE SHEET - continued
30 NOVEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 August 2024 and were signed on its behalf by:





Dr D C Stokes - Director


CAMBRIDGE MEDICAL PARTNERS LIMITED (REGISTERED NUMBER: 11659362)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

1. STATUTORY INFORMATION

Cambridge Medical Partners Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on cost
Motor vehicles - 25% on cost
Computer equipment - 33% on cost

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


CAMBRIDGE MEDICAL PARTNERS LIMITED (REGISTERED NUMBER: 11659362)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 December 2022 1,831 - 1,488 3,319
Additions 1,242 20,000 1,768 23,010
Disposals - - (1,488 ) (1,488 )
At 30 November 2023 3,073 20,000 1,768 24,841
DEPRECIATION
At 1 December 2022 814 - 1,488 2,302
Charge for year 707 5,000 583 6,290
Eliminated on disposal - - (1,488 ) (1,488 )
At 30 November 2023 1,521 5,000 583 7,104
NET BOOK VALUE
At 30 November 2023 1,552 15,000 1,185 17,737
At 30 November 2022 1,017 - - 1,017

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 December 2022
and 30 November 2023 3,150
NET BOOK VALUE
At 30 November 2023 3,150
At 30 November 2022 3,150

CAMBRIDGE MEDICAL PARTNERS LIMITED (REGISTERED NUMBER: 11659362)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 NOVEMBER 2023

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 3,659 -

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 10,278 13,658
Other creditors 42,967 50,135
53,245 63,793